Health
COVID-19 vaccine candidate is 96.4 percent effective in mice, study shows – Drug Target Review
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
Posted: 1 December 2020 | Victoria Rees (Drug Target Review) | No comments yet
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
A new COVID-19 vaccine candidate has shown success in mouse models by inducing high levels of antibodies against the S1 fragment of the SARS-CoV-2 Spike (S) protein.
Developed by BioVaxys Technology, the vaccine, called BVX-0320, did not produce any toxicity in the mice. According to the researchers,…
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business23 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News22 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers